(Q28259868)

S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature)

20 April 2017

1 reference

The three-dimensional solution structure of Ca(2+)-bound S100A1 as determined by NMR spectroscopy

20 April 2017

1 reference

Three-dimensional solution structure of the calcium-signaling protein apo-S100A1 as determined by NMR

20 April 2017

1 reference

Intracellular and extracellular roles of S100 proteins

20 April 2017

1 reference

Hydrophobic residues in the C-terminal region of S100A1 are essential for target protein binding but not for dimerization

20 April 2017

1 reference

S100A1: Structure, Function, and Therapeutic Potential

20 April 2017

1 reference

S100A1: a multifaceted therapeutic target in cardiovascular disease

20 April 2017

1 reference

S100A1 in cardiovascular health and disease: closing the gap between basic science and clinical therapy

20 April 2017

1 reference

Transcriptional regulation of S100A1 and expression during mouse heart development

20 April 2017

1 reference

Ca2+ -dependent interaction of S100A1 with the sarcoplasmic reticulum Ca2+ -ATPase2a and phospholamban in the human heart

20 April 2017

1 reference

S100A1 increases the gain of excitation-contraction coupling in isolated rabbit ventricular cardiomyocytes

20 April 2017

1 reference

Distinct subcellular location of the Ca2+-binding protein S100A1 differentially modulates Ca2+-cycling in ventricular rat cardiomyocytes

20 April 2017

1 reference

Transgenic overexpression of the Ca2+-binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performance

20 April 2017

1 reference

Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction

20 April 2017

1 reference

S100A1: a regulator of myocardial contractility

20 April 2017

1 reference

S100A1 decreases calcium spark frequency and alters their spatial characteristics in permeabilized adult ventricular cardiomyocytes

20 April 2017

1 reference

Interaction of S100A1 with the Ca2+ release channel (ryanodine receptor) of skeletal muscle

20 April 2017

1 reference

Titin-actin interaction in mouse myocardium: passive tension modulation and its regulation by calcium/S100A1

20 April 2017

1 reference

Titin-isoform dependence of titin-actin interaction and its regulation by S100A1/Ca2+ in skinned myocardium

20 April 2017

1 reference

Altered expression of the Ca(2+)-binding protein S100A1 in human cardiomyopathy

20 April 2017

1 reference

S100A1 genetically targeted therapy reverses dysfunction of human failing cardiomyocytes

20 April 2017

1 reference

Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue

20 April 2017

1 reference

S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction

20 April 2017

1 reference

Impaired cardiac contractility response to hemodynamic stress in S100A1-deficient mice

20 April 2017

1 reference

Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model

20 April 2017

1 reference

S100A1: Another Step Toward Therapeutic Development for Heart Failure

20 April 2017

1 reference

Gene therapy targets in heart failure: the path to translation

20 April 2017

1 reference

Heart disease and stroke statistics--2011 update: a report from the American Heart Association

20 April 2017

1 reference

Cardiac hypertrophy: the good, the bad, and the ugly

20 April 2017

1 reference

Genomics, transcriptional profiling, and heart failure

20 April 2017

1 reference

Is depressed myocyte contractility centrally involved in heart failure?

21 January 2018

1 reference

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology

21 January 2018

1 reference

Heart failure therapy at a crossroad: are there limits to the neurohormonal model?

21 January 2018

1 reference

Gene therapy in heart failure

21 January 2018

1 reference

Calcium cycling and signaling in cardiac myocytes.

21 January 2018

1 reference

Prospects for gene therapy for heart failure

21 January 2018

1 reference

Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure

21 January 2018

1 reference

A review of the S100 proteins in cancer

21 January 2018

1 reference

Calcium-dependent and -independent interactions of the S100 protein family.

21 January 2018

1 reference

Molecular mechanisms of S100-target protein interactions

21 January 2018

1 reference

Affinity of S100A1 protein for calcium increases dramatically upon glutathionylation

21 January 2018

1 reference

Redox modifications of the C-terminal cysteine residue cause structural changes in S100A1 and S100B proteins.

21 January 2018

1 reference

S100A1: a regulator of striated muscle sarcoplasmic reticulum Ca2+ handling, sarcomeric, and mitochondrial function

21 January 2018

1 reference

S100ao (alpha alpha) protein is mainly located in the heart and striated muscles

21 January 2018

2 references

21 January 2018

7 January 2021

S100a0 (alpha alpha) protein in cardiac muscle. Isolation from human cardiac muscle and ultrastructural localization.

1 reference

Right ventricular upregulation of the Ca(2+) binding protein S100A1 in chronic pulmonary hypertension

21 January 2018

1 reference

Isolation of a rat S100α cDNA and distribution of its mRNA in rat tissues

21 January 2018

1 reference

Endothelial S100A1 modulates vascular function via nitric oxide.

21 January 2018

1 reference

Lack of S100A1 in mice confers a gender-dependent hypertensive phenotype and increased mortality after myocardial infarction

21 January 2018

1 reference

Co-expression/co-location of S100 proteins (S100B, S100A1 and S100A2) and protein kinase C (PKC-beta, -eta and -zeta) in a rat model of cerebral basilar artery vasospasm.

21 January 2018

1 reference

Ca2+ -dependent interaction of S100A1 with F1-ATPase leads to an increased ATP content in cardiomyocytes

21 January 2018

1 reference

Understanding ATP synthesis: structure and mechanism of the F1-ATPase (Review)

21 January 2018

1 reference

Cardiac energy metabolism homeostasis: role of cytosolic calcium

21 January 2018

1 reference

Cardiac titin: structure, functions and role in disease

21 January 2018

1 reference

The small EF-hand Ca 2+ binding protein S100A1 increases contractility and Ca 2+ cycling in rat cardiac myocytes

21 January 2018

1 reference

Animal models of human cardiovascular disease, heart failure and hypertrophy

21 January 2018

1 reference

Animal models of cardiovascular diseases

21 January 2018

1 reference

Rescuing the failing heart by targeted gene transfer

21 January 2018

1 reference

Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial.

21 January 2018

1 reference

S100a0 (alpha alpha) protein: distribution in muscle tissues of various animals and purification from human pectoral muscle

21 January 2018

1 reference

7 January 2021

Cardiac adenoviral S100A1 gene delivery rescues failing myocardium

1 reference

7 January 2021

Myocardial fibrosis from severe carbon monoxide poisoning detected by cardiac magnetic resonance imaging

1 reference

7 January 2021

release_6yt37i6tmjdtvgbdhsvwvusxh4

Identifiers

DOI

10.1038/GT.2012.8

0 references

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6yt37i6tmjdtvgbdhsvwvusxh4

24 November 2022